<p>This is data on the 15 feasibility trials found in a
systematic review of randomised controlled trials (RCTs) accessing routinely
collected health data (RCHD) in the UK. The systematic review, published in
2020<sup>1</sup>, considered successful applications for RCHD (such as NHS
Digital) detailed in publicly accessible release registers. The release
registers were searched in January to May 2019 and data was extracted on every
RCT receiving data between 2013 and 2018. This dataset comprises information on
the 15 feasibility trials who received routine data during this period.</p>
<p>A paper detailing the methodology and findings has been published: Mirza A, Yorke-Edwards V, Lensen S et al. Why are feasibility studies accessing routinely collected health data? A systematic review. F1000Research 2021, 10:815</p><p><br></p>
<p>The dataset is provided as a .txt file, with columns
separated by | [pipe/ vertical bar]. </p><p>The PRISMA 2020 checklist<sup>2</sup> for the submitted paper is provided as a .pdf file</p><p><br></p>
<p> 1. Lensen S, Macnair A, Love SB, et al. Access to
routinely collected health data for clinical trials - review of successful data
requests to UK registries. Trials 2020; 21. doi: 10.1186/s13063-020-04329-8</p><p> 2. Page MJ,
McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA
2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. doi: 10.1136/bmj.n71<br></p><p><br></p><p>In
Version 2 the PRISMA checklist was added: the dataset remains unchanged. In Version 3 the description and references were updated to include the publication associated with this dataset.</p><p></p><p><br></p>
I confirm that I am not uploading any: personal data as defined by data protection legislation, including information that may identify a living individual; information provided in confidence; or information that would contravene a third-party agreement
Yes
I have considered whether the data to be published may be licensed commercially before deciding to freely release it to the public. Further information and advice may be sought from UCL Business https://www.uclb.com/about/our-people/